Stock Trading History of Cornelius James M

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cornelius James M since year 2005. The trader's CIK number is 1198959. At the time of this reporting, Cornelius James M is the Chairman & CEO of Bristol Myers Squibb Co . (stock ticker symbol (BMY)). See this page for all insider trading activities at Bristol Myers Squibb Co .
Note that in the past CORNELIUS JAMES M also reported insider trading activities as an insider of the following companies:

Insider Activities at Bristol Myers Squibb Co ((BMY))
Insider Activities at Directv Group Inc (DTV)
Insider Activities at Chubb Corp (CB)
Insider Activities at National Bank Of Indianapolis Corp (N/A)
Insider Activities at Guidant Corp (GDT)

Stock purchases, sales, and option exercises reported by insider *Cornelius James M* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-05-07	BMY	Bristol Myers Squibb Co	Purchase	100,000	22.81	2,280,826
2007-02-12	DTV	Directv Group Inc	Option Exercise	5,500	.00	0
2006-10-26	DTV	Directv Group Inc	Option Exercise	5,000	16.54	82,700
2006-10-13	CB	Chubb Corp	Option Exercise	16,000	38.47	615,520
2006-05-19	CB	Chubb Corp	Option Exercise	32,000	30.25	967,920
2006-05-19	CB	Chubb Corp	Sale	32,000	50.37	1,611,840
2006-05-19	CB	Chubb Corp	Option Exercise	32,000	30.25	967,920
2006-05-19	CB	Chubb Corp	Sale	32,000	50.37	1,611,840
2006-03-22	N/A	National Bank Of Indianapolis Corp	Option Exercise	6,000	18.83	112,999
2005-08-12	DTV	Directv Group Inc	Purchase	50,000	16.06	803,149
2005-08-09	CB	Chubb Corp	Sale	11,000	87.72	964,865
2005-07-18	GDT	Guidant Corp	Sale	285,000	68.15	19,421,895

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cornelius James M (Chairman & CEO of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.